Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Krajnc

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Neurology|May 1, 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MSTobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, et al.
European Journal of Neurology|June 25, 2022
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control studyGabriel Bsteh, Hamid Assar, Christiane Gradl, et al.
European Journal of Neurology|March 5, 2026
Surgical Interventions in Idiopathic Intracranial Hypertension-A Comprehensive Multi-Center Study of Outcome and the Role of Treatment IndicationGabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
European Journal of Neurology|July 6, 2022
Impact of vaccination on COVID-19 outcome in multiple sclerosisGabriel Bsteh, Christiane Gradl, Bettina Heschl, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|February 1, 2022
Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort studyGabriel Bsteh, Harald Hegen, Gerhard Traxler, et al.
Neurology|September 29, 2025
Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple SclerosisGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|July 7, 2022
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter studyNik Krajnc, Harald Hegen, Gerhard Traxler, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Neurology|May 1, 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MSTobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, et al.
European Journal of Neurology|June 25, 2022
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control studyGabriel Bsteh, Hamid Assar, Christiane Gradl, et al.
European Journal of Neurology|March 5, 2026
Surgical Interventions in Idiopathic Intracranial Hypertension-A Comprehensive Multi-Center Study of Outcome and the Role of Treatment IndicationGabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, et al.
Multiple Sclerosis and Related Disorders|August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC scoreGabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
European Journal of Neurology|July 6, 2022
Impact of vaccination on COVID-19 outcome in multiple sclerosisGabriel Bsteh, Christiane Gradl, Bettina Heschl, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|February 1, 2022
Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort studyGabriel Bsteh, Harald Hegen, Gerhard Traxler, et al.
Neurology|September 29, 2025
Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple SclerosisGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|July 7, 2022
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter studyNik Krajnc, Harald Hegen, Gerhard Traxler, et al.
Pageof 7